All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Not reported | 2019-000105-73 | Efficacy of metfOrmin in PrevenTIng glucocorticoid-induced diabetes in Melanoma, breAst or Lung cancer patients with brain metastases: the phase II OPTIMAL study Studio OPTIMAL: Studio di fase II d... | 2024-01-31 | due-trials |
| Not reported | 2018-004299-37 | NIVOLUMAB plus IPILIMUMAB and TEMOZOLOMIDE in combination in microsatellite stable (MSS), MGMT silenced metastatic colorectal cancer (mCRC): the MAYA study. Trattamento di combinazione con NIVOLUMA... | 2023-07-10 | due-trials |
| Not reported | 2017-000579-10 | An open label, single-arm, phase 2 study of pembrolizumab and nanoparticle albumin-bound paclitaxel in patients with metastatic urothelial carcinoma after chemotherapy failure; the PEANUT study Stu... | 2022-10-21 | due-trials |
| Not reported | 2015-004596-72 | A phase II study evaluating the efficacy of enzalutamide and the role of ARv7 in metastatic castration resistant prostate cancer (mCRPC) patients with visceral disease Studio di fase II per valuta... | 2023-12-28 | due-trials |
| Not reported | 2015-004472-30 | Randomized phase III trial on Trabectedin (ET-743) vs clinician's choice chemotherapy in recurrent ovarian, primary peritoneal or fallopian tube cancers of BRCA mutated or BRCAness phenotype patients ... | 2022-02-24 | due-trials |
| Not reported | 2014-003227-21 | Phase II study on Inlyta® (axitinib) in recurrent and/or metastatic salivary gland cancers (SGCs) of the upper aerodigestive tract Studio di fase 2 con Inlyta® (Axitinib) nel tumore delle ghiandole... | 2019-03-15 | due-trials |
| Not reported | 2014-002175-28 | Efficacy and safety of single agent pan-HER inhibitor Dacomitinib in the treatment of locally advanced unresectable or metastatic squamous cell cancer of the skin or with clinical contraindication to... | 2022-06-15 | due-trials |
| Not reported Terminated | 2014-001956-52 | Activity and safety of third line tyrosin kinase inhibitor (TKI) after 2 tyrosin kinase inhibitors(TKIs) in patients with metastatic renal cell carcinoma (mRCC) (Tokio Study) Attività e sicurezza d... | 2017-11-08 | due-trials |
| Not reported | 2014-001274-34 | Phase II trial of abiraterone acetate in patients with relapsed and/or metastatic, castration resistant, salivary gland cancers. Studio di fase II con abiraterone acetato nel paziente con tumore ... | 2023-05-26 | due-trials |
| Not reported Terminated | 2014-000777-38 | Activity and safety of second line SOrafenib After Pazopanib in patients with metastatic renal cell carcinoma (SOAP Study) Attività e sicurezza della seconda linea con sorafenib dopo pazopanib nei ... | 2017-11-08 | due-trials |
| Not reported | 2014-000043-32 | A Phase 2 study of Paclitaxel and Ifosfamide plus either Cisplatin or Carboplatin for patients with metastatic non-transitional cell carcinoma of the bladder and the urinary tract | 2020-10-22 | due-trials |
| Not reported | 2013-005596-40 | Phase II Study of Axitinib in Advanced Solitary Fibrous Tumor Studio di fase 2 su Axitinib nel tumore solitario fibroso avanzato | 2020-02-04 | due-trials |
| Not reported | 2013-005282-39 | Effects of high Intra-abdominal pressure on tissue diffusion and pharmacokinectics of cisplatin during HIPEC Gli effetti dell’alta pressione intra-addominale sulla diffusione tissutale e sulla farm... | 2017-12-13 | due-trials |
| Not reported | 2013-003319-23 | SUBLINGUAL FENTANYL VERSUS SUBCUTANEOUS MORPHINE FOR THE MANAGEMENT OF SEVERE CANCER PAIN EPISODES IN PATIENTS ON OPIOID TREATMENT: A DOUBLE-BLIND RANDOMIZED NON–INFERIORITY TRIAL. fentanyl subl... | 2015-08-17 | due-trials |
| Not reported | 2013-001362-42 | Perioperative treatment with COI-B (Capecitabine, Oxaliplatin, Irinotecan and Bevacizumab) of high risk or borderline resectable colorectal liver metastases Trattamento perioperatorio con COI-B (Ca... | 2018-01-15 | due-trials |
| Reported results Terminated | 2012-002059-40 | Potentiating clinical and immunological effects of chemotherapy by neutralizing acidic pH at tumor site: a phase II randomized study in melanoma patients Potenziamento degli effetti clinici e immun... | 2013-06-20 | due-trials |
| Not reported | 2012-000382-20 | Peritoneal Mesothelioma: Optimize Outcomes by the Integration of new Prognostic Factors and Potential Therapeutic Targets in a Individualized Treatment based on Molecular Characterization and Chemosen... | 2019-11-29 | due-trials |
| Not reported | 2011-006234-16 | Evaluation of the efficacy of the tandem treatment [90Y-DOTA, TYR(3)]OCTREOTATE and [177Lu-DOTA, TYR(3)]OCTREOTATE in patients with neuroendocrine tumour expressing somatostatin receptors and refracto... | 2017-12-31 | due-trials |
| Not reported | 2011-006205-95 | Toremifene in desmoid tumor: prospective clinical trial and identification of potential molecular targets Toremifene nel tumore desmoide: studio clinico prospettico e identificazione di potenziali ... | 2020-09-07 | due-trials |
| Not reported | 2011-005983-12 | Phase II study of the fully human monoclonal antibody against transforming growth factor-beta (TGF-beta) receptor ALK1 (PF-03446962) in relapsed or refractory urothelial cancer (UC) failing first-line... | 2013-09-09 | due-trials |
| Not reported | 2011-005248-81 | Differentiated thyroid cancer: metabolic radiotherapy with high activity of radioiodine calculated by individual pre-therapy dosimetry Carcinoma tiroideo differenziato: radioterapia metabolica con ... | 2017-12-31 | due-trials |
| Not reported | 2011-002564-24 | Cetuximab and Cisplatin with or without Paclitaxel in recurrent/metastatic head and neck cancer Cetuximab e Cisplatino con o senza Paclitaxel nel tumore testa-collo ricorrente o metastatico | 2017-07-14 | due-trials |
| Not reported | 2010-022653-41 | Phase II study of neoadjuvant cisplatin and gemcitabine plus sorafenib for patients with transitional cell carcinoma of the bladder. | 2016-12-31 | due-trials |
| Not reported | 2010-021755-34 | Phase II study on imatinib in combination with RAD001 in advanced chordoma | 2019-05-24 | due-trials |
| Not reported | 2010-020375-24 | Sorafenib in recurrent and/or metastatic salivary gland carcinomas | 2014-12-15 | due-trials |
| Not reported Terminated | 2010-020305-32 | A phase II, open label study to evaluate the activity and safety of Everolimus in association to Imatinib in PDGFRA-D842V unresectable or metastatic gastrointestinal stromal tumours (GISTs)as fi... | 2014-11-25 | due-trials |
| Reported results | 2010-018869-29 | PHASE II STUDY OF NILOTINIB EFFICACY IN PIGMENTED VILLO-NODULAR SYNOVITIS/ TENOSYNOVIAL GIANT CELL TUMOUR (PVNS/TGCT) | 2013-10-04 | due-trials |
| Not reported | 2009-017798-39 | An open label, Phase II study of vaccination with Survivin peptides emulsified in Montanide ISA 51VG after IMP 321 injection in prostate carcinoma patients with biochemical failure (PROVAX study) | 2014-04-15 | due-trials |
| Not reported | 2009-009418-42 | Phase II study evaluating efficacy and tolerability of Sorafenib in the treatment of iatrogenic lymphedema occurring in breast cancer patients following surgical dissection of, and/or radiotherapy on ... | 2011-11-01 | due-trials |
| Not reported | 2008-002202-18 | CALENDULA POMADE VERSUS PLACEBO CREAM/CORTISONE CREAM (FLUORCORTOLONE) IN THE PREVENTION OF CUTANEOUS ERYTHEMA DUE TO BREAST IRRADIATION. A RANDOMIZED STUDY ON 60 PATIENTS | 2012-11-14 | due-trials |
| Not reported | 2008-001062-93 | Perioperative treatment with COI-E (capecitabine, oxaliplatin, irinotecan and cetuximab) of liver metastasis of colorectal carcinoma potentially resectable although at high risk of recurrences | 2015-07-22 | due-trials |
| Not reported | 2005-003676-38 | CAPECITABINE TIME TABLE AND RADIOTHERAPY AS ADJUVANT THERAPY IN RECTAL CANCER | 2009-06-21 | due-trials |